Disclosures for "Time to Gabapentinoid Initiation and Opioid use Among Medicare Beneficiaries in the Post-stroke Recovery Period"
-
Mrs. Bustamante Rocha has nothing to disclose.
-
Julianne Brooks has nothing to disclose.
-
Maria Donahue has nothing to disclose.
-
Dr. Moura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Moura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Moura has received research support from Centers for Diseases Control and Prevention (CDC SIP20-007) . The institution of Dr. Moura has received research support from Epilepsy Foundation of America . The institution of Dr. Moura has received research support from NIH - NIA and NINDS. Dr. Moura has received personal compensation in the range of $50,000-$99,999 for serving as a Expert Advisor with Epilepsy Foundation .